JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

Search

Twist Bioscience Corp

Fermé

SecteurSoins de santé

47.79 3.94

Résumé

Variation du prix de l'action

24h

Actuel

Min

45.02

Max

48.58

Chiffres clés

By Trading Economics

Revenu

-48M

-27M

Ventes

3M

99M

Marge bénéficiaire

-27.41

Employés

979

EBITDA

3.2M

-21M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+11.09% upside

Dividendes

By Dow Jones

Prochains Résultats

4 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

733M

2.6B

Ouverture précédente

43.85

Clôture précédente

47.79

Sentiment de l'Actualité

By Acuity

50%

50%

152 / 352 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

Twist Bioscience Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

3 févr. 2026, 23:11 UTC

Principaux Mouvements du Marché
Acquisitions, Fusions, Rachats

Silicon Laboratories Shares Up On Report of $7 Billion Texas Instruments Acquisition Deal

3 févr. 2026, 23:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3 févr. 2026, 23:50 UTC

Market Talk

Nikkei May Decline After Hitting All-Time High -- Market Talk

3 févr. 2026, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Technical Correction -- Market Talk

3 févr. 2026, 23:41 UTC

Acquisitions, Fusions, Rachats

KKR Makes AI Play With $10.9B Asia Data-Center Deal

3 févr. 2026, 23:38 UTC

Résultats

AMD Sales Climb on Help From Data-Center Business -- Update

3 févr. 2026, 23:29 UTC

Acquisitions, Fusions, Rachats

KKR-Consortium Deal in STT GDC Is One of the Largest Digital-Infrastructure Transactions in Southeast Asia

3 févr. 2026, 23:27 UTC

Acquisitions, Fusions, Rachats

Netflix, Warner Defend Proposed Deal in Senate Hearing -- WSJ

3 févr. 2026, 23:25 UTC

Acquisitions, Fusions, Rachats

KKR-Consortium Expects Deal to Close by Early 2H of 2026

3 févr. 2026, 23:23 UTC

Acquisitions, Fusions, Rachats

KKR Consortium With Singtel to Own 75% and 25% Stake in ST Telemedia Global Data Centres

3 févr. 2026, 23:22 UTC

Acquisitions, Fusions, Rachats

KKR-Led Consortium to Buy Singapore-Based Global Data-Center Provider Valued at S$13.8B

3 févr. 2026, 23:19 UTC

Market Talk

Australia Gold Miners Tipped to Rally Higher -- Market Talk

3 févr. 2026, 23:19 UTC

Market Talk

Global Equities Roundup: Market Talk

3 févr. 2026, 22:56 UTC

Principaux Mouvements du Marché
Acquisitions, Fusions, Rachats

Silicon Laboratories Shares Up On Report of $7B Texas Instruments Acquisition Deal

3 févr. 2026, 22:40 UTC

Résultats

Amdocs Extends Collaboration With T-Mobile

3 févr. 2026, 22:39 UTC

Résultats

Amdocs 1Q Adj EPS $1.81

3 févr. 2026, 22:39 UTC

Résultats

Amdocs 1Q Rev $1.16B

3 févr. 2026, 22:39 UTC

Résultats

Amdocs 1Q EPS $1.45 >

3 févr. 2026, 22:38 UTC

Résultats

Amdocs: Shimie Hortig to Succeed Shuky Sheffer as President and CEO, Effective March 31

3 févr. 2026, 22:30 UTC

Acquisitions, Fusions, Rachats

Bob Iger's Second Time as CEO Wasn't Great for the Stock. He Still Leaves Behind A Strong Legacy. -- Barrons.com

3 févr. 2026, 22:22 UTC

Acquisitions, Fusions, Rachats

Texas Instruments Nearing $7B Deal for Silicon Laboratories, Sources Tell FT

3 févr. 2026, 22:14 UTC

Résultats

AMD Expects to Scale AI Business to Tens of Billions in Annual Sales in 2027, CEO Says

3 févr. 2026, 22:13 UTC

Résultats

AMD Expects Data-Center Unit Sales to Jump More Than 60% a Year Over Next Three to Five Years, CEO Says

3 févr. 2026, 22:12 UTC

Résultats

AMD in Talks With Several Companies About At-Scale, Multi-Year Chip Deployments, CEO Says

3 févr. 2026, 22:10 UTC

Résultats

AMD CEO: Eight of 10 Biggest AI Companies Use Instinct Chip to Power Production Workloads

3 févr. 2026, 22:10 UTC

Résultats

Blackstone Stock, Alternative Managers, BDCs Dive as Software Woes Infect Private Credit -- Barrons.com

3 févr. 2026, 22:10 UTC

Market Talk

Key Drivers Underpinning Shaw's Bullish View of Gold Intact -- Market Talk

3 févr. 2026, 22:10 UTC

Résultats

AMD CEO: Enterprises Are Modernizing Data Centers to Have Compute Needed for New AI Workflows

3 févr. 2026, 22:09 UTC

Résultats

AMD CEO: Hyperscalers Expanding Infrastructure to Meet Growing Cloud-Services Demand in AI

3 févr. 2026, 22:09 UTC

Résultats

AMD CEO: Demand Accelerated Across Data Center, Gaming and PC

Comparaison

Variation de prix

Twist Bioscience Corp prévision

Objectif de Prix

By TipRanks

11.09% hausse

Prévisions sur 12 Mois

Moyen 52 USD  11.09%

Haut 58 USD

Bas 50 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

6 ratings

6

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

31.56 / 38.6884Support & Résistance

Court Terme

Very Strong Bearish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

152 / 352Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat